The uptake of active surveillance for the management of prostate cancer: A population-based analysis

被引:17
|
作者
Richard, Patrick O. [1 ,2 ,3 ,4 ,5 ]
Alibhai, Shabbir M. H. [3 ,6 ]
Panzarella, Tony [3 ,7 ]
Klotz, Laurence [3 ,8 ]
Komisarenko, Maria [1 ,2 ,3 ]
Fleshner, Neil E. [1 ,2 ,3 ]
Urbach, David [3 ,9 ]
Finelli, Antonio [1 ,2 ,3 ]
机构
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg, Div Urol, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] CHU Sherbrooke, Dept Surg, Div Urol, Sherbrooke, PQ, Canada
[5] Univ Sherbrooke, Sherbrooke, PQ, Canada
[6] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[7] Univ Hlth Network, Princess Margaret Hosp, Biostat Dept, Toronto, ON, Canada
[8] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON, Canada
[9] Univ Hlth Network, Dept Surg, Toronto, ON, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2016年 / 10卷 / 9-10期
关键词
FOLLOW-UP; COHORT; MEN; OUTCOMES; GUIDELINES; TRENDS; TIME; CARE;
D O I
10.5489/cuaj.3684
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Active surveillance (AS) is a strategy for the management of low-risk prostate cancer (PCa). However, few studies have assessed the uptake of AS at a population level and none of these were based on a Canadian population. Therefore, our objectives were to estimate the proportion of men being managed by AS in Ontario and to assess the factors associated with its uptake. Methods: This was a retrospective, population-based study using administrative databases from the province of Ontario to identify men <= 75 years diagnosed with localized PCa between 2002 and 2010. Descriptive statistics were used to estimate the proportion of men managed by AS, whereas mixed models were used to assess the factors associated with the uptake of AS. Results: 45 691 men met our inclusion criteria. Of these, 18% were managed by AS. Over time, the rates of AS increased significantly from 11% to 21% (p<0.001). Older age, residing in an urban centre, being diagnosed in the later years of the study period, having a neighborhood income in the highest quintile, and being managed by urologists were all associated with greater odds of receiving AS. Conclusions: There has been a steady increase in the uptake of AS between 2002 and 2010. However, only 18% of men diagnosed with localized PCa were managed by AS during the study period. The decisions to adopt AS were influenced by several individual and physician characteristics. The data suggest that there is significant opportunity for more widespread adoption of AS.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [31] Prostate Cancer and the Increasing Role of Active Surveillance
    Alonzo, David Gabriel
    Mure, Amanda Lynne
    Soloway, Mark S.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 109 - 116
  • [32] Update and optimization of active surveillance in prostate cancer
    Rubio-Briones, J.
    Pastor Navarro, B.
    Esteban Escano, L. M.
    Borque Fernando, A.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (01): : 1 - 7
  • [33] Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study
    Timilshina, Narhari
    Finelli, Antonio
    Tomlinson, George
    Sander, Beate
    Alibhai, Shabbir M. H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (05): : 465 - +
  • [34] Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts
    Inoue, Lurdes Y. T.
    Lin, Daniel W.
    Newcomb, Lisa F.
    Leonardson, Amy S.
    Ankerst, Donna
    Gulati, Roman
    Carter, H. Ballentine
    Trock, Bruce J.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Klotz, Laurence H.
    Mamedov, Alexandre
    Penson, David F.
    Etzioni, Ruth
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (01) : 1 - +
  • [35] A novel predictor of clinical progression in patients on active surveillance for prostate cancer
    Tan, Guan Hee
    Finelli, Antonio
    Ahmad, Ardalan
    Wettstein, Marian S.
    Chandrasekar, Thenappan
    Zlotta, Alexandre R.
    Fleshner, Neil E.
    Hamilton, Robert J.
    Kulkarni, Girish S.
    Ajib, Khaled
    Nason, Gregory
    Perlis, Nathan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (08): : 250 - 255
  • [36] How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States
    Loeb, Stacy
    Walter, Dawn
    Curnyn, Caitlin
    Gold, Heather T.
    Lepor, Herbert
    Makarov, Danil V.
    JOURNAL OF UROLOGY, 2016, 196 (03) : 721 - 726
  • [37] Management of low risk prostate cancer: active surveillance and focal therapy
    Klotz, Laurence
    Emberton, Mark
    CURRENT OPINION IN UROLOGY, 2014, 24 (03) : 270 - 279
  • [38] Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance
    Eltemamy, Mohamed M.
    Leapman, Michael S.
    Cowan, Janet E.
    Westphalen, Antonio
    Shinohara, Katsuto
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2016, 196 (03) : 727 - 732
  • [39] Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study
    Matta, Rano
    Hird, Amanda E.
    Dvorani, Erind
    Saskin, Refik
    Nason, Gregory J.
    Kulkarni, Girish
    Kodama, Ronald T.
    Herschorn, Sender
    Nam, Robert K.
    CANCER MEDICINE, 2020, 9 (19): : 6946 - 6953
  • [40] Active surveillance in intermediate risk prostate cancer: is it safe?
    Krishnananthan, Nishanth
    Lawrentschuk, Nathan
    INTERNATIONAL BRAZ J UROL, 2016, 42 (03): : 418 - 421